Posted: May 22nd, 2023

The major strategy this project focuses on is the use of dedicated nanostructures

The major strategy this project focuses on is the use of dedicated nanostructures for the production of life-saving medication, which includes protein synthesis and monoclonal antibodies to reduce the cost of production and increase the number of patients receiving the drugs (Gray 2014). Platform technology comprises of hereditary production of recombinant cells and transmission of the hereditary substances into animal cells for protein generation. The project also seeks to investigate the cleansing and classification of the medication, in planning for human or animal trials (Gray 2014).

Another research study investigates the mechanisms involved when nano-particles contribute to the regeneration of cancer cells. The studies focus on directed distribution of nano-substances transporting cytotoxic medications to cancerous cells (Mahler 2014). Other target cells and antibodies designed for the target cells are being investigated (Mahler 2014). This is achieved by the conjugation of antibody particles to nano-fragments through different chemical and technological methods (Mahler 2014).